{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:30:21Z","timestamp":1775766621369,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T00:00:00Z","timestamp":1552262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Agency for the Promotion of Science and Technology (ANPCyT), Ministry of Science, Technology and Innovative Production (MINCyT) of Argentina.","award":["PICT 2012-1729"],"award-info":[{"award-number":["PICT 2012-1729"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13346-019-00628-z","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T15:13:30Z","timestamp":1552317210000},"page":"935-944","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["High-dose intramyocardial HMGB1 induces long-term cardioprotection in sheep with myocardial infarction"],"prefix":"10.1007","volume":"9","author":[{"given":"Mar\u00eda del Rosario","family":"Bauz\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Sebasti\u00e1n","family":"Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"De Lorenzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Hnatiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio C.","family":"Capogrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Crottogini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Cuniberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6938-0430","authenticated-orcid":false,"given":"Fernanda Daniela","family":"Olea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"key":"628_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2017.04.052","volume":"70","author":"GA Roth","year":"2017","unstructured":"Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1\u201325.","journal-title":"J Am Coll Cardiol"},{"key":"628_CR2","first-page":"840","volume":"73","author":"SR Tiyyagura","year":"2006","unstructured":"Tiyyagura SR, Pinney SP. Left ventricular remodeling after myocardial infarction: past, present, and future. Mt Sinai J Med. 2006;73:840\u201351.","journal-title":"Mt Sinai J Med"},{"key":"628_CR3","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","volume":"67","author":"GW Stone","year":"2016","unstructured":"Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol. 2016;67:1674\u201383.","journal-title":"J Am Coll Cardiol"},{"key":"628_CR4","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ijcard.2014.07.107","volume":"176","author":"R Gnavi","year":"2014","unstructured":"Gnavi R, Rusciani R, Dalmasso M, Giammaria M, Anselmino M, Roggeri DP, et al. Gender, socioeconomic position, revascularization procedures and mortality in patients presenting with STEMI and NSTEMI in the era of primary PCI. Differences or inequities? Int J Cardiol. 2014;176:724\u201330.","journal-title":"Int J Cardiol"},{"key":"628_CR5","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/eurpub\/ckw062","volume":"26","author":"G Luca De","year":"2016","unstructured":"De Luca G, Petrelli A, Landriscina T, Gnavi R, Giammaria M, Costa G. Geographic and socioeconomic differences in access to revascularization following acute myocardial infarction. Eur J Pub Health. 2016;26:760\u20135.","journal-title":"Eur J Pub Health"},{"key":"628_CR6","first-page":"271","volume":"107","author":"JS Rebou\u00e7as","year":"2016","unstructured":"Rebou\u00e7as JS, Santos-Magalh\u00e3es NS, Formiga FR. Cardiac regeneration using growth factors: advances and challenges. Arq Bras Cardiol. 2016;107:271\u20135.","journal-title":"Arq Bras Cardiol"},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biomaterials.2015.12.025","volume":"82","author":"HK Awada","year":"2016","unstructured":"Awada HK, Hwang MP, Wang Y. Towards comprehensive cardiac repair and regeneration after myocardial infarction: aspects to consider and proteins to deliver. Biomaterials. 2016;82:94\u2013112.","journal-title":"Biomaterials"},{"key":"628_CR8","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1074248417735399","volume":"23","author":"M Guo","year":"2018","unstructured":"Guo M, Shi JH, Wang PL, Shi DZ. Angiogenic growth factors for coronary artery disease: current status and prospects. J Cardiovasc Pharmacol Ther. 2018;23:130\u201341.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"628_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.gde.2005.08.007","volume":"15","author":"ME Bianchi","year":"2005","unstructured":"Bianchi ME, Agresti A. HMG proteins: dynamic players in gene regulation and differentiation. Curr Opin Genet Dev. 2005;15:496\u2013506.","journal-title":"Curr Opin Genet Dev"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"e1001086","DOI":"10.1371\/journal.pbio.1001086","volume":"9","author":"B Celona","year":"2011","unstructured":"Celona B, Weiner A, Di Felice F, Mancuso FM, Cesarini E, Rossi RL, et al. Substantial histone reduction modulates genomewide nucleosomal occupancy and global transcriptional output. PLoS Biol. 2011;9:e1001086. https:\/\/doi.org\/10.1371\/journal.pbio.1001086 .","journal-title":"PLoS Biol"},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00018-018-2930-9","volume":"76","author":"A Raucci","year":"2019","unstructured":"Raucci A, Di Maggio S, Scavello F, D\u2019Ambrosio A, Bianchi M, Capogrossi MC. The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci. 2019;76:211\u201329.","journal-title":"Cell Mol Life Sci"},{"key":"628_CR12","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/cvr\/cvn163","volume":"80","author":"T Kitahara","year":"2008","unstructured":"Kitahara T, Takeishi Y, Harada M, Niizeki T, Suzuki S, Sasaki T, et al. Highmobility group box 1 restores cardiac function after myocardial infarction in transgenic mice. Cardiovasc Res. 2008;80:40\u20136.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"628_CR13","doi-asserted-by":"publisher","first-page":"e19845","DOI":"10.1371\/journal.pone.0019845","volume":"6","author":"F Limana","year":"2011","unstructured":"Limana F, Esposito G, D'Arcangelo D, Di Carlo A, Romani S, Melillo G, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and mir-206- mediated inhibition of timp-3. PLoS One. 2011;6(6):e19845. https:\/\/doi.org\/10.1371\/journal.pone.0019845 .","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"628_CR14","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1161\/CIRCULATIONAHA.107.757443","volume":"118","author":"K Takahashi","year":"2008","unstructured":"Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, et al. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation. 2008;118(Suppl 1):S106\u201314.","journal-title":"Circulation"},{"key":"628_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/743879","volume":"2012","author":"X Zhou","year":"2012","unstructured":"Zhou X, Hu X, Xie J, Xu C, Xu W, Jiang H. Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation. J Biomed Biotechnol. 2012;2012:1\u20135. https:\/\/doi.org\/10.1155\/2012\/743879 .","journal-title":"J Biomed Biotechnol"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1016\/j.bbadis.2017.07.012","volume":"1863","author":"S Maggio Di","year":"2017","unstructured":"Di Maggio S, Milano G, De Marchis F, D\u2019Ambrosio A, Bertolotti M, Palacios BS, et al. Non-oxidizable HMGB1 induces cardiac fibroblasts migration via CXCR4 in a CXCL12-independent manner and worsens tissue remodeling after myocardial infarction. Biochim Biophys Acta Mol basis Dis. 2017;1863:2693\u2013704.","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"628_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00109-015-1356-1","volume":"94","author":"YF Qi","year":"2016","unstructured":"Qi YF, Zhang J, Wang L, Shenoy V, Krause E, Oh SP, et al. Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. J Mol Med. 2016;94:37\u201349.","journal-title":"J Mol Med"},{"key":"628_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ejphar.2018.03.041","volume":"828","author":"G Zhang","year":"2018","unstructured":"Zhang G, Zhang X, Li D, Tian J, Jiang W. Long-term oral atazanavir attenuates myocardial infarction-induced cardiac fibrosis. Eur J Pharmacol. 2018;828:97\u2013102.","journal-title":"Eur J Pharmacol"},{"key":"628_CR19","doi-asserted-by":"publisher","first-page":"E16","DOI":"10.1093\/ilar.52.1.E16","volume":"52","author":"P Locatelli","year":"2011","unstructured":"Locatelli P, Olea FD, Mendiz O, Salmo F, Fazzi L, Hnatiuk A, et al. An ovine model of postinfarction dilated cardiomyopathy in animals with highly variable coronary anatomy. ILAR J. 2011;52:E16\u201321.","journal-title":"ILAR J"},{"key":"628_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1089\/104303403322319390","volume":"14","author":"A Crottogini","year":"2003","unstructured":"Crottogini A, Meckert PC, Vera Janavel G, Lascano E, Negroni J, Del Valle H, et al. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther. 2003;14:1307\u201318.","journal-title":"Hum Gene Ther"},{"key":"628_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/jgm.478","volume":"6","author":"R Laguens","year":"2004","unstructured":"Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, et al. Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med. 2004;6:222\u20137.","journal-title":"J Gene Med"},{"key":"628_CR22","first-page":"258","volume":"4","author":"P Locatelli","year":"2011","unstructured":"Locatelli P, Olea FD, De Lorenzi A, Salmo F, Vera Janavel GL, Hnatiuk AP, et al. Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans. Int J Clin Exp Med. 2011;4:258\u201364.","journal-title":"Int J Clin Exp Med"},{"key":"628_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF02889344","volume":"15","author":"W Gr\u00e4bner","year":"1974","unstructured":"Gr\u00e4bner W, Pfitzer P. Number of nuclei in isolated myocardial cells of pigs. Virchows Arch B Cell Pathol. 1974;15:279\u201394.","journal-title":"Virchows Arch B Cell Pathol"},{"key":"628_CR24","first-page":"159","volume":"429","author":"CP Adler","year":"1996","unstructured":"Adler CP, Friedburg H, Herget GW, Neuburger M, Schwalb H. Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts. Virchows Arch. 1996;429:159\u201364.","journal-title":"Virchows Arch"},{"key":"628_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/206039","volume":"2013","author":"JJ Haan de","year":"2013","unstructured":"de Haan JJ, Smeets MB, Pasterkamp G, Arslan F. Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediat Inflamm. 2013;2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/206039 .","journal-title":"Mediat Inflamm"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1161\/01.RES.0000186276.06104.04","volume":"97","author":"F Limana","year":"2005","unstructured":"Limana F, Germani A, Zacheo A, Kajstura J, Di Carlo A, Borsellino G, et al. Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ Res. 2005;97:e73\u201383.","journal-title":"Circ Res"},{"key":"628_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.5551\/jat.27235","volume":"22","author":"Y Nakamura","year":"2015","unstructured":"Nakamura Y, Suzuki S, Shimizu T, Miyata M, Shishido T, Ikeda K, et al. High mobility group box 1 promotes angiogenesis from bone marrow-derived endothelial progenitor cells after myocardial infarction. J Atheroscler Thromb. 2015;22:570\u201381.","journal-title":"J Atheroscler Thromb"},{"key":"628_CR28","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1152\/physrev.00029.2005","volume":"86","author":"N Westerhof","year":"2006","unstructured":"Westerhof N, Boer C, Lamberts R, Sipkema P. Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev. 2006;86:1263\u2013308.","journal-title":"Physiol Rev"},{"key":"628_CR29","first-page":"277","volume-title":"The heart. Physiology and metabolism","author":"LH Opie","year":"1991","unstructured":"Opie LH. Oxygen supply: coronary flow. In: Opie LH, editor. The heart. Physiology and metabolism. 2nd ed. New York: Raven Press; 1991. p. 277\u201381.","edition":"2"},{"key":"628_CR30","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1152\/physiolgenomics.00023.2004","volume":"18","author":"K Tang","year":"2004","unstructured":"Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD. Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. Physiol Genomics. 2004;18:63\u20139.","journal-title":"Physiol Genomics"},{"key":"628_CR31","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/sj.gt.3302481","volume":"12","author":"MJ Gounis","year":"2005","unstructured":"Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB, et al. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 2005;12:762\u201371.","journal-title":"Gene Ther"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/gt.2009.30","volume":"16","author":"FD Olea","year":"2009","unstructured":"Olea FD, Vera Janavel G, Cuniberti L, Yannarelli G, Cabeza Meckert P, Cors J, et al. Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther. 2009;16:716\u201323.","journal-title":"Gene Ther"},{"key":"628_CR33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4049\/jimmunol.176.1.12","volume":"176","author":"S Mitola","year":"2006","unstructured":"Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol. 2006;176:12\u20135.","journal-title":"J Immunol"},{"key":"628_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1161\/CIRCRESAHA.108.181115","volume":"103","author":"JA Clayton","year":"2008","unstructured":"Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res. 2008;103:1027\u201336.","journal-title":"Circ Res"},{"key":"628_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/S0012-1606(03)00385-3","volume":"262","author":"FA Stennard","year":"2003","unstructured":"Stennard FA, Costa MW, Elliott DA, Rankin S, Haast SJ, Lai D, et al. Cardiac T-box factor Tbx20 directly interacts with Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the developing heart. Dev Biol. 2003;262:206\u201324.","journal-title":"Dev Biol"},{"key":"628_CR36","doi-asserted-by":"publisher","unstructured":"Boogerd CJ, Zhu X, Aneas I, Sakabe NJ, Zhang L, Sobreira DR, et al. Tbx20 is required in mid-gestation cardiomyocytes and plays a central role in atrial development. Circ Res. 2018. https:\/\/doi.org\/10.1161\/CIRCRESAHA.118.311339 .","DOI":"10.1161\/CIRCRESAHA.118.311339"},{"key":"628_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1189\/jlb.0306165","volume":"81","author":"A Germani","year":"2007","unstructured":"Germani A, Limana F, Capogrossi MC. Pivotal advances: high-mobility group box 1 protein - a cytokine with a role in cardiac repair. J Leukoc Biol. 2007;81:41\u20135.","journal-title":"J Leukoc Biol"},{"key":"628_CR38","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/jcp.25576","volume":"232","author":"E Foglio","year":"2017","unstructured":"Foglio E, Puddighinu G, Germani A, Russo MA, Limana F. HMGB1 inhibits apoptosis following MI and induces autophagy via mTORC1 inhibition. J Cell Physiol. 2017;232:1135\u201343.","journal-title":"J Cell Physiol"},{"key":"628_CR39","doi-asserted-by":"publisher","first-page":"39721","DOI":"10.1074\/jbc.M105253200","volume":"276","author":"S AbdAlla","year":"2001","unstructured":"AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U. The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem. 2001;276:39721\u20136.","journal-title":"J Biol Chem"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13346-019-00628-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-019-00628-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T17:12:43Z","timestamp":1663089163000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13346-019-00628-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s13346-019-00628-z","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]},"assertion":[{"value":"11 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were carried out in accordance with the Guide for Care and Use of Laboratory Animals, published by the US National Institutes of Health (NIH Publication No. 85\u201323, revised 1996) and approved and monitored by the Laboratory Animal Care and Use Committee (CICUAL) of the Favaloro University (approval # DCT0157-12). The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}